Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Signal Transduction and Targeted Therapy
|
October 5, 2023
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
Ying Fang, Mu-Chen Zhang, Yang He, et al.
Autophagy
|
January 7, 2016
Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation
Meng-Meng Ji, Li Wang, Qin Zhan, et al.
Annals of Translational Medicine
|
November 18, 2021
Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients
Xing Fan, Lu Zang, Bing-Bing Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2022
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
Peng-Peng Xu, Rong Shen, Zi-Yang Shi, et al.
Clinical Epigenetics
|
October 24, 2020
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
Mu-Chen Zhang, Ying Fang, Li Wang, et al.
Clinical and Translational Medicine
|
November 30, 2020
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma
Rong Shen, Peng-Peng Xu, Nan Wang, et al.
Ebiomedicine
|
February 4, 2017
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study
Peng-Peng Xu, Hui-Juan Zhong, Yao-Hui Huang, et al.
Practical Radiation Oncology
|
July 6, 2026
Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial
Shu-Bei Wang, Jia-Yi Chen, Qi Song, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Nature Communications
|
June 18, 2024
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi-Xun Yan, Yan Dong, Niu Qiao, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Signal Transduction and Targeted Therapy
|
October 5, 2023
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
Ying Fang, Mu-Chen Zhang, Yang He, et al.
Autophagy
|
January 7, 2016
Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation
Meng-Meng Ji, Li Wang, Qin Zhan, et al.
Annals of Translational Medicine
|
November 18, 2021
Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients
Xing Fan, Lu Zang, Bing-Bing Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2022
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
Peng-Peng Xu, Rong Shen, Zi-Yang Shi, et al.
Clinical Epigenetics
|
October 24, 2020
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
Mu-Chen Zhang, Ying Fang, Li Wang, et al.
Clinical and Translational Medicine
|
November 30, 2020
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma
Rong Shen, Peng-Peng Xu, Nan Wang, et al.
Ebiomedicine
|
February 4, 2017
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study
Peng-Peng Xu, Hui-Juan Zhong, Yao-Hui Huang, et al.
Practical Radiation Oncology
|
July 6, 2026
Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial
Shu-Bei Wang, Jia-Yi Chen, Qi Song, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Nature Communications
|
June 18, 2024
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi-Xun Yan, Yan Dong, Niu Qiao, et al.
Page
of 9